Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intensity Modulated Radiation Treatments Followed by A Stereotactic CyberKnife Boost Focused on the Gross Residual Pelvic Tumor Volume

NCT03206385 is registered in ClinicalTrials.gov with Centre Francois Baclesse, Luxembourg as lead sponsor.

NCT NCT03206385
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03206385 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intensity Modulated Radiation Treatments Followed by A Stereotactic CyberKnife Boost Focused on the Gross Residual Pelvic Tumor Volume
Lead sponsor
Centre Francois Baclesse, Luxembourg
Phase
Observational
Overall status
Unknown status
Start date
May 31, 2017
Completion date
December 31, 2023
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pelvis tumors